Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07488117
PHASE2
Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?
Sponsor: University Hospital, Toulouse
View on ClinicalTrials.gov
Summary
This study aims to evaluate the effectiveness of \[18F\]-DPA-714 PET imaging in detecting neuroimmune activity in patients with autoimmune encephalitis (AE). The primary objective is to compare \[18F\]-DPA-714 binding in AE patients to healthy controls.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-03
Completion Date
2028-01
Last Updated
2026-03-23
Healthy Volunteers
Yes
Conditions
Interventions
OTHER
TEP with radioligand EAI 714
60-minutes \[18F\]-DPA-714 PET imaging
Locations (1)
University Hospital
Toulouse, France